Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

George Doherty

1PUBLICATIONS

29CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 04, 2024

BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors.

Andrew S Judd, Bhupinder Bawa, Wayne R Buck

Pageof 1

Frequent Collaborators

1 joint publications

Andrew S Judd

1 joint publications

Bhupinder Bawa

1 joint publications

Wayne R Buck

1 joint publications

Zhi-Fu Tao

1 joint publications

Yingchun Li

1 joint publications

Kenneth R Durbin

1 joint publications

Robin Frey

1 joint publications

Deanna Haasch

1 joint publications

Sandra Haman

1 joint publications

Anthony R Haight

Frequent Collaborators

1 joint publications

Andrew S Judd

1 joint publications

Bhupinder Bawa

1 joint publications

Wayne R Buck

1 joint publications

Zhi-Fu Tao

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos